Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Therapists are cautious about sharing personal information. When they fall ill or die unexpectedly, the shock can be ...

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be attending, exhibiting, ...

Luminaries of the music world mourned the death Tuesday of Ozzy Osbourne at age 76, expressing affection and admiration for ...

GPs are set to play a key role in delivering care for people with mild and moderate ME/CFS under a new delivery plan.

To address the gap in sepsis management bundle compliance at a community hospital in Cleveland, Ohio, the authors created an intervention targeting patients who presented with sepsis upon admission, ...

A new framework published in JAMA Internal Medicine offers a systematic approach to this challenge. Researchers described the ...

McArthur Davis was 18 when doctors told him to burn his clothes to cure what they thought was an infection. His vision was ...

Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis Provided by GlobeNewswire Jul 9, 2025, 4:00:00 AM ...

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a Strong Buy.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

The API failed to deliver the resource. Dr. Richard Carpenos and his patient share how a non-surgical treatment at New England Spine and Disc is making a difference.